Using a differential display RT-PCR strategy to identify novel growth-facto
r-induced transcripts, we cloned and characterized the human homolog of yea
st NOP5/NOP58, whose gene product has been implicated in the execution of e
arly pre-rRNA processing steps. Human NOP5 cDNA was isolated from an M426 f
ibroblast cDNA library. Determination of the cDNA nucleotide sequence revea
led an open reading frame of 1587 nucleotides encoding a predicted gene pro
duct of 529 amino acids and mass of 59 554 Da. The yeast and human NOP5 gen
e products were found to share 63% homology and 46% identity. NOP5 mRNA was
induced within 2 h of platelet-derived growth factor (PDGF) treatment of h
uman M426 fibroblasts. Pretreatment with cycloheximide enhanced, while acti
nomycin blocked induction of the NOP5 transcript. In vitro translational an
alysis of the cDNA revealed a 60 kDa species? consistent with the predicted
molecular weight of the gene product. Ubiquitous, but differential NOP5 mR
NA expression was revealed after Northern blot analysis of total RNA from s
everal human tissues. Moreover, NOP5 mRNA expression was also demonstrated
in cell lines of fibroblast, epithelial, and myeloid origin. A highly charg
ed carboxy terminal domain and consensus phosphorylation sites were identif
ied. The presence of potential regulatory elements, together with growth fa
ctor induction and widespread expression is consistent with the hypothesis
that the NOP5 gene product may play a role in fundamental cellular growth p
rocesses. (C) 2000 Elsevier Science B.V. All rights reserved.